PsilodexMedication × psilocybin
Your list , 0 items
Medication class

Diabetes medications and psilocybin.

22 records in this group. None has published human data with psilocybin or another classic psychedelic; the rest draw on each medication's own pharmacology and label. State rules are summarized for Colorado, Oregon and New Mexico.

22Records
0With human data

Also searched as diabetes medication · diabetes medicine · insulin · blood sugar medication

01 What the evidence covers

Best evidence available per medication
22No psilocybin data
No psilocybin data: no human data with psilocybin or another classic psychedelic; the text draws on the medication's own pharmacology and its label or reference facts

02 Each medication

A to Z
  • Dapagliflozin · FarxigaEvidence: No psilocybin data

    Type 2 diabetes (with diet and exercise); Heart failure

    Not studied with psilocybin; fluid loss can lower blood pressure and may add to dehydration. Also, fasting raises its risk of ketoacidosis (acid buildup).

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Dulaglutide · TrulicityEvidence: No psilocybin data

    Type 2 diabetes (with diet and exercise); Lowering risk of heart attack, stroke, and cardiovascular death in type 2 diabetes

    Its nausea may add to psilocybin's, and it may delay psilocybin's onset (untested). Also, with insulin or a sulfonylurea, blood sugar can drop too low.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Empagliflozin · JardianceEvidence: No psilocybin data

    Type 2 diabetes (with diet and exercise); Heart failure

    Not studied with psilocybin. Also, it can cause dehydration and low blood pressure, and eating less, such as fasting, can trigger ketoacidosis.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Exenatide · Byetta, Bydureon BCiseEvidence: No psilocybin data

    Type 2 diabetes (with diet and exercise)

    Its nausea may add to psilocybin's nausea. Also, with insulin or a sulfonylurea, blood sugar can drop too low.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Glimepiride · AmarylEvidence: No psilocybin data

    Type 2 diabetes (with diet and exercise)

    Around a psilocybin session, blood sugar may drop too low with light or skipped meals.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Glipizide · GlucotrolEvidence: No psilocybin data

    Type 2 diabetes (with diet and exercise)

    Around a psilocybin session, blood sugar may drop too low with light or skipped meals.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Insulin aspart · Novolog, FiaspEvidence: No psilocybin data

    Diabetes

    Low blood sugar may be confused with, or intensify, psilocybin's effects; it is more likely with light meals or nausea.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Insulin degludec · TresibaEvidence: No psilocybin data

    Diabetes

    Low blood sugar may be confused with, or intensify, psilocybin's effects; it is more likely with light meals or nausea.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Insulin degludec–liraglutide · Xultophy 100/3.6Evidence: No psilocybin data

    Type 2 diabetes (with diet and exercise)

    It may slow psilocybin absorption and add nausea, and its insulin can lower blood sugar. Stopping or pausing it can raise blood sugar.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Insulin detemir · LevemirEvidence: No psilocybin data

    Diabetes

    Low blood sugar can be confused with, or intensify, psilocybin's effects; it is its most common side effect, more likely with light meals or nausea.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Insulin efsitora alfa · OnswikEvidence: No psilocybin data

    Type 2 diabetes mellitus in adults (glycemic control)

    Low blood sugar may be confused with, or intensify, psilocybin's effects; it is more likely with light meals or nausea.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Insulin glargine · Lantus, Basaglar, Toujeo, Semglee, RezvoglarEvidence: No psilocybin data

    Type 1 diabetes; Type 2 diabetes

    Low blood sugar may be confused with, or intensify, psilocybin's effects; it is more likely with light meals or nausea.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Insulin glargine–lixisenatide · SoliquaEvidence: No psilocybin data

    Type 2 diabetes (with diet and exercise)

    It may slow psilocybin absorption and add nausea, and its insulin can lower blood sugar. Stopping or pausing it can raise blood sugar.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Insulin human NPH/regular · Humulin 70/30, Humulin N, Novolin N, Novolin 70/30Evidence: No psilocybin data

    Diabetes

    Low blood sugar may be confused with, or intensify, psilocybin's effects; it is more likely with light meals or nausea.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Insulin icodec · AwiqliEvidence: No psilocybin data

    Type 2 diabetes mellitus in adults (glycemic control)

    Low blood sugar may be confused with, or intensify, psilocybin's effects; it is more likely with light meals or nausea.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Insulin lispro · Humalog, Admelog, LyumjevEvidence: No psilocybin data

    Diabetes

    Not studied with psilocybin; low-blood-sugar symptoms may overlap with psilocybin's effects and be hard to recognize, and light or skipped meals raise the risk.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Liraglutide · Victoza, SaxendaEvidence: No psilocybin data

    Type 2 diabetes (with diet and exercise); Reducing heart attack, stroke and cardiovascular death risk in type 2 diabetes with heart disease

    Its nausea may add to psilocybin's, and its effect on psilocybin absorption is unknown. Also, blood sugar can drop when used with insulin or sulfonylureas.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Metformin · GlucophageEvidence: No psilocybin data

    Type 2 diabetes (with diet and exercise; adults, and children 10 and older for immediate-release)

    Not studied with psilocybin; no linking mechanism is described. Also, it can cause stomach upset.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Pioglitazone · ActosEvidence: No psilocybin data

    Type 2 diabetes (with diet and exercise)

    Not studied with psilocybin; no linking mechanism is described. Also, fluid retention and, with some diabetes drugs, low blood sugar can occur.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Semaglutide · Ozempic, WegovyEvidence: No psilocybin data

    Type 2 diabetes (with diet and exercise); Lowering heart attack, stroke and cardiovascular death risk in type 2 diabetes

    Its nausea can add to psilocybin's, and it may delay absorption of oral psilocybin. Also, blood sugar can drop with insulin or sulfonylureas.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Sitagliptin · JanuviaEvidence: No psilocybin data

    Type 2 diabetes (with diet and exercise)

    Not studied with psilocybin; no linking mechanism is described. Also, on its own it rarely causes low blood sugar.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Tirzepatide · Mounjaro, ZepboundEvidence: No psilocybin data

    Type 2 diabetes (with diet and exercise); Lowering risk of major cardiovascular events in type 2 diabetes

    It may delay absorption of oral psilocybin (not studied), and its nausea can add to psilocybin's. Also, blood sugar can drop with insulin or sulfonylureas.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

03 Properties the records flag

Records with each flag
19Hypoglycemia risk
8Dehydration or electrolyte risk
7Slows gastric emptying
3Raises blood pressure or heart rate
2Lowers blood pressure or causes orthostasis
2Withdrawal or rebound if stopped abruptly

Flags describe a medication's own properties, each cited in its record. A flag is not a finding about any combination. Definitions are on the Method page.

04 State rules

Official text governs
COColorado · final · checked 2026-10-24

No provision names these medications or this group.

OROregon · final · checked 2026-10-24

No provision names these medications or this group.

NMNew Mexico · pending · checked 2026-10-24

Rules not final; the proposed rules reviewed name no medication in this group.

05 Studies cited in this group

Records citing each
14Halman A, Kong G, Sarris J, Perkins D. Drug–drug interactions involving classic psychedelics: a systematic review. J Psychopharmacol 2024;38(1):3–18.
14Sarparast A, Thomas K, Malcolm B, Stauffer CS. Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology 2022;239(6):1945–1976.

Related classes

Records reviewed 2026-10-03 to 2026-11-02. Each row summarizes one record; the full record, with every source, opens in the browser and is not sent to the server. All classes · Browse A–Z

AgreementPsilodex

Before you use Psilodex

Check each box to continue.

Your searches, your list and the medications you look up stay in this browser. We can't see them. Privacy · Emergency: 911 · Mental health crisis: call or text 988 · Poison Control: 1-800-222-1222

Terms version 2026-10-25